14th Annual New Therapeutics in Hematology and Oncology: The Road to Personalized Medicine

This important educational activity will provide guidance to front-line and oncology clinicians, nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists, with the most current information available about new agents in hematology and oncology and translating of the latest research to their patients. The conference will cover drug and treatment updates with a focus on precision medicine, gynecological malignancies, hematologic malignancies, prostate, bladder cancer, and GI malignancies. The conference features a comprehensive review of new drugs approved along with their mechanism of action, and a keynote lecture, Stand Up to Cancer focusing on developmental therapeutics. Next generation studies will also be addressed, and the conference will off er participants a session designed to provide insight into the latest advances in lung cancer treatment, including integration of new molecularly-targeted therapies and immunotherapy.

1. Evaluate new, emerging and novel therapeutic agents, advances in care, and clinical trial data and apply relevant findings into the management of cancer patients
2. Develop personalized treatment plans for patients based upon an evaluation of efficacy and safety of current and newly approved agents and therapeutic options
3. Integrate appropriate strategies into clinical practice to optimize the management of patients with gynecologic malignancies to improve patient outcomes
4. Utilize AJCC or other appropriate staging in clinical practice, including appropriate prognostic indicators and evidencebased national guidelines for treatment planning
5. Review the principles, techniques, and applications of precision medicine, including genomic and molecular profiling, biomarker discovery, targeted therapies, and personalized care, in order to appreciate the potential benefits, limitations, and ethical considerations of this emerging approach to healthcare

In- person Fee
Physicians (In-Person) : Free
All Other Healthcare Providers (In- Person): Free
Residents/Fellows/Medical Students (In- Person): Free
CSHS Advanced Practice Providers/Researchers/Administration (In- Person): Free
Industry (No Exhibit Booth ): $275.00

Refund Policy
All cancellations must be submitted in writing and refunds will be subject to an administrative charge. To view the policy, click here. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548.  

Disclaimer
All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner without the express permission of Cedars-Sinai.

Right to Cancel or Postpone
Cedars-Sinai reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event that Cedars-Sinai must cancel or postpone this course, the registration fee will be fully refunded. Cedars-Sinai is not responsible for any related costs, charges or expenses to participants, including fees assessed by airline, travel or lodging agencies.

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 10.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Jhoane Estacio
Cedars-Sinai Medical Center

Activity Administrator

Nothing to disclose

Joan Vasquez
Cedars-Sinai Medical Center

Activity Administrator

Nothing to disclose

Robert A. Figlin, MD
Cedars-Sinai

Course Director

Nothing to disclose

John Chute, MD
Cedars-Sinai

Course Director, Faculty

Nothing to disclose

Karen Reckamp, MD
Cedars-Sinai

Course Director, Faculty

Consultant-Pfizer, Inc. (Relationship has ended)|Consultant-Merus (Relationship has ended)|Consultant-AstraZeneca (Relationship has ended)|Consultant-Daiichi Sankyo (Relationship has ended)|Consultant-Novartis AG|Consultant-Janssen|Consultant-Genentech, Inc.|Consultant-GlaxoSmithKline|PrincipalNamedInvestigator-Elevation Oncology|PrincipalNamedInvestigator-Daiichi Sankyo|PrincipalNamedInvestigator-Blueprint|PrincipalNamedInvestigator-Genentech, Inc.|PrincipalNamedInvestigator-Janssen

Natasha Banerjee, MD
cedars sinai

Faculty

Consultant-AstraZeneca (Relationship has ended)

Jin Sun Bitar, MD
Cedars Sinai Medical Center

Faculty

Consultant-Novartis AG (Relationship has ended)|Consultant-Biotheraostic (Relationship has ended)

Alisa Blumenthaler, MD
Cedars-Sinai

Faculty

Nothing to disclose

Andrea Cercek, MD
Memorial Sloan Kettering Cancer Center

Faculty

David Chan, MD
Hunt Cancer Center, Torrance Memorial

Faculty

Nothing to disclose

Luxi Chen, MD, PhD

Faculty

Nothing to disclose

Alice Chung, MD
Cedars-Sinai Medical Center

Faculty

Justin Darrah, MD
Cedars-Sinai

Faculty

Advisor-Genmab (Relationship has ended)

Jane C. Figueiredo , PhD
Cedars-Sinai Medical Center

Faculty

Nothing to disclose

Alexandra Gangi, MD
Cedars Sinai

Faculty

Nothing to disclose

Armando E. Giuliano, MD
Cedars Sinai Medical Center

Faculty

Nothing to disclose

Jun Gong, MD
Cedars-Sinai

Faculty

Advisor-Agenus (Relationship has ended)|Advisor-AstraZeneca (Relationship has ended)|Advisor-BeOne (Relationship has ended)|Advisor-Exelixis (Relationship has ended)|Advisor-Caper Labs (Relationship has ended)|Advisor-Natera (Relationship has ended)|Advisor-Bayer Corporation (Relationship has ended)|Advisor-Genentech (Relationship has ended)|Advisor-Incyte (Relationship has ended)|Advisor-Eisai, Inc. (Relationship has ended)|Advisor-Taiho Pharmaceutical (Relationship has ended)|Advisor-Seagen (Relationship has ended)

Navid Hafez, MD
The Angeles Clinic and Research Institute - West Los Angeles Office

Faculty

Advisor-Pfizer, Inc. (Relationship has ended)|Advisor-Bristol-Myers Squibb (Relationship has ended)|Speaker-Bristol-Myers Squibb|PrincipalNamedInvestigator-Genentech, Inc. (Relationship has ended)

Andrew E. Hendifar, MD
Cedars-Sinai

Faculty

Hitomi Hosoya, MD, PhD
Stanford University

Faculty

Nothing to disclose

Andrew Li, MD
Cedars-Sinai Medical Center

Faculty

Louisa Liu, MD

Faculty

Jeremy Lorber, MD
Cedars-Sinai

Faculty

Speaker-Sanofi-Aventis

Thomas Lowe, MD
Torrance Memorial

Faculty

Inderjit Mehmi, MD
Cedars-Sinai

Faculty

Noah Merin, MD, PhD
Cedars-Sinai

Faculty

Arsen Osipov, MD
Cedars-Sinai

Faculty

David R. Oveisi, MD
Cedars Sinai Medical Center

Faculty

Ronald Paquette, MD
Cedars-Sinai

Faculty

Edwin M Posadas, MD
Cedars-Sinai

Faculty

Speaker-Bayer Corporation|Advisor-cytolumina (Relationship has ended)|Speaker-Myovant (Relationship has ended)

Jeremy Rudnick, MD
CSMC

Faculty

Kamya Sankar, MD
Cedars-Sinai Medical Center

Faculty

Nothing to disclose

Joshua Sasine, MD, PhD
Cedars-Sinai

Faculty

Nothing to disclose

Kevin Scher, MD

Faculty

Jeannie Shen, MD

Faculty

Stephen Shiao, MD, PhD
Cedars-Sinai

Faculty

Robert Vescio, MD
Cedars-Sinai

Faculty

Yuan Yuan, MD, PhD
Cedars Sinai Cancer

Faculty